PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
11-Apr-2022 CureVac and GSK Enter into Pandemic Preparedness Contract with German Government CureVac
11-Apr-2022 PEI Regulatory Approval Received for Government Funded Clinical Trial Investigating Adrenomed's Adrecizumab in Treating Endothelial Barrier Dysfunction in Hospitalized COVID-19 Patients Adrenomed AG
11-Apr-2022 Watson-Marlow Fluid Technology Solutions’ new name reflects strategy focused on delivering end-to-end fluid management solutions for customers Sciad Newswire
11-Apr-2022 SciRhom Starts CMC Development of its First Drug Candidate for Clinical Development B3C newswire
08-Apr-2022 Merck & Pfizer’s BAVENCIO® ▼ (avelumab) now recommended as an option as a maintenance therapy for eligible patients with locally advanced or metastatic urothelial carcinoma following NICE appeal Merck & Pfizer
08-Apr-2022 F-star Therapeutics Presents a Novel LAG-3 Reduction and Shedding Mechanism with FS118 at AACR 2022 F-star Therapeutics
08-Apr-2022 DOUGLAS closes acquisition of Disapo Douglas GmbH
08-Apr-2022 INEOS Nitriles is to invest in a world-scale Acetonitrile plant in Cologne to meet European Demand. INEOS Nitriles
08-Apr-2022 Top Results for Vetter in University of St. Gallen Benchmarking Vetter
08-Apr-2022 Genmab Announces the Initial Resolution of its Arbitration with Janssen Relating to their Daratumumab License Agreement Genmab
08-Apr-2022 Beiersdorf Aktiengesellschaft: Sales growth in the first quarter of 2022 above capital markets expectations Beiersdorf Aktiengesellschaft
08-Apr-2022 Eckert & Ziegler: Radboud University Medical Center Netherlands to Image First Patient with PENTIXAFOR Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Apr-2022 Original-Research: Haemato AG (von First Berlin Equity Research GmbH) Haemato AG
08-Apr-2022 MagForce AG: MagForce USA, Inc. receives Payment Code Approval by the American Medical Association for the Focal Ablation of Prostate Cancer with the NanoTherm Therapy System MagForce AG
08-Apr-2022 Medartis has decided not to pursue the convertible bond placement Medartis Holding AG
08-Apr-2022 Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb Evotec SE
07-Apr-2022 Evolva’s AGM postponed to May 5, 2022 / agenda remains unchanged Evolva Holding SA
07-Apr-2022 Medartis launches senior convertible bond offering with a target size of CHF 125-150 million Medartis Holding AG
07-Apr-2022 Top Results for Vetter in University of St. Gallen Benchmarking B3C newswire
07-Apr-2022 Geratherm Medical AG: Geratherm Medical AG announces preliminary figures for financial year 2021 Geratherm Medical AG